Visualization in the UMAP space of samples corresponding to the subtypes ER+ (a), HER2+ (b), and TN (c). The samples were categorized by cancer subtype and integrated. Cells are color-coded according ...
We performed spatial transcriptomics of estrogen receptor (ER)–negative, ER-low, and ER-high tumor regions of breast cancers that were intermediate (10%-60%) ER ...
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an ...
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the Recurrence Score in node-positive breast cancer: Independent validation in the PACS-01 trial. This is an ASCO Meeting ...
Hosted on MSN
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an ...
The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback